BioCentury
ARTICLE | Company News

Arigene, Trimeris deal

January 4, 2010 8:00 AM UTC

Arigene terminated its offer to acquire Trimeris at $3.60 per share, or about $82.1 million, after Arigene was unable to secure sufficient financing. The 86.4% of Trimeris shares that had been tendere...